Ad
ADMA - ADMA Biologics Inc Stock Trading
About | ADMA Biologics Inc (NASDAQ:ADMA)
ADMA Biologics is a late stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma based biologics for the treatment and prevention of certain infectious diseases. Our targeted patient populations include immune compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune suppressed for medical reasons. Our product candidates are intended to be used by physician specialists focused on caring for immune compromised patients with infectious diseases. ADMA also operates ADMA BioCenters, an FDA licensed, GHA certified source plasma collection facility which provides a portion of blood plasma for the manufacture of the our lead product candidate RI .
Quote | ADMA Biologics Inc (NASDAQ:ADMA)
| Last: | $3.795 |
|---|---|
| Change Percent: | 2.57% |
| Open: | $3.7 |
| Close: | $3.70 |
| High: | $3.83 |
| Low: | $3.64 |
| Volume: | 663,748 |
| Last Trade Date Time: | 12/01/2023 03:00:00 am |
News | ADMA Biologics Inc (NASDAQ:ADMA)
-
2023-11-17 18:29:00 ET Adma Biologics (NASDAQ: ADMA) finished the trading week on a high note, with its shares racing more than 4% higher in price on Friday. Investors were happy about the specialty healthcare company's latest news about its growing network of plasma-collection faci...
-
2023-11-16 07:37:44 ET More on ADMA Biologics ADMA Biologics: Achieving Important Inflection Points ADMA Biologics, Inc. (ADMA) Q3 2023 Earnings Call Transcript ADMA Biologics: From Plasma To Profits With A Pinch Of Prudence ADMA Biologics Q3 2023 Earnings Pr...
Message Board Posts | ADMA Biologics Inc (NASDAQ:ADMA)
| Subject | By | Source | When |
|---|---|---|---|
| $ADMA Adma Biologics Inc | mick | investorshub | 04/30/2023 9:11:34 PM |
| ad-ma $ADMA | mick | investorshub | 04/15/2023 3:16:50 PM |
| $ADMA Adma Biologics Inc | mick | investorshub | 02/27/2023 12:15:20 AM |
| Looks like a double pointed top forming I | bude | investorshub | 02/09/2023 3:08:09 PM |
| Look at the weekly and monthly charts for | bude | investorshub | 02/09/2023 1:42:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2023-11-17 18:29:00 ET Adma Biologics (NASDAQ: ADMA) finished the trading week on a high note, with its shares racing more than 4% higher in price on Friday. Investors were happy about the specialty healthcare company's latest news about its growing network of plasma-collection faci...
-
RAMSEY, N.J. and BOCA RATON, Fla. and LAUREL, Md., Nov. 16, 2023 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-...
-
2023-11-09 16:25:06 ET Adma Biologics (NASDAQ: ADMA) stock experienced a nice pop in Thursday's trading session, after the company unveiled its latest set of quarterly earnings after market hours the previous day. Happy investors were trading the shares up by almost 5% late in the s...